Cidara Therapeutics Inc buy klostergang
Start price
21.04.17
/
50%
€6.04
Target price
04.11.21
€5.00
Performance (%)
-70.74%
End price
17.06.21
€1.77
Summary
This prediction ended on 17.06.21 with a price of €1.77. Massive losses of -70.74% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cidara Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by klostergang for this prediction
In the thread Cidara Therapeutics Inc diskutieren
klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
klostergang stimmt am 21.04.2017 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.
Kursziel geändert auf 5,0